Study Reveals the 8 Best Photos to Use in Your Dating Profile
LOS ANGELES, March 20, 2023 (Newswire.com)
–
A new study, conducted by The Match Lab, has revealed the eight best types of photos to use in a datin…
The post Study Reveals the 8 Best Photos to Use in Your Dating Profile first appeared on RSVTV news.
Common Health Launches Southeast Asia’s First E-Commerce Platform for Chronic Diseases
New Service Helps Save Money, Improve Health for Population of 151 Million
PROVIDENCE, R.I., March 19, 2023 (Newswire.com)
–
Common Health Inc., an American startup company working in Southeast Asia, announced today the launch of a new e-commerce platform dedicated to the region’s 151 million people with diabetes and hypertension. The service makes quality medicines more accessible and affordable, and provides advice and support to help customers live longer, healthier lives. Common Health is now available in Myanmar and can be accessed through www.commonhealth.com.mm, Facebook, Viber, and a telephone hotline.
Chronic diseases are a serious challenge in the region, where 99 million people are diabetic or pre-diabetic and 116 million people have hypertension, including many with both conditions. Due to the high costs for care and the complexities of living with these diseases, most people struggle to maintain their treatment. For example, only 12% of people in Southeast Asia with hypertension have their condition under control.
Common Health addresses this by making products and services for people with chronic diseases more affordable, accessible, and convenient, starting with essential medications. Every customer using the company’s platform has access to:
- Low prices that deliver savings on every order, made possible by relationships with pharmacies, distributors, and manufacturers,
- Convenient home delivery by a dedicated team trained on the safe handling of health products, including “cold-chain” items,
- A wide range of medications for diabetes, hypertension, and hyperlipidemia, including Myanmar’s largest selection of oral diabetes drugs and insulins,
- A world-class quality guarantee ensuring that products are authentic, legally imported, and in excellent condition, and
- Free telemedicine support, including a family medicine doctor matched to each household and a 24-hour on-call service for urgent issues.
The company has piloted its chronic disease e-commerce platform in the cities of Yangon and Bago, and the response from customers like Daw Cho Cho Thein has been enthusiastic. “We save 25,000 kyats [~US$ 12] per family member on medication costs by ordering through Common Health,” said Thein, who cares for two parents with type 2 diabetes. “We do not need to worry about the expiration date on the medicines. And whenever we have questions, we call our family medicine doctor.”
Common Health was founded in 2019 by Matthew Guilford, who previously scaled telemedicine and health insurance to five million people in Bangladesh. The company began operations in Myanmar in 2021, supporting primary care, medicine delivery, and hospital access for 31,000 children and pregnant women. In less than two years, Common Health’s platform has been used to provide more than 140,000 telemedicine consultations and to deliver more than 17,000 medication orders.
“We are excited to launch this service as a first step in helping families across Southeast Asia save money and achieve better health outcomes,” said Guilford. “We look forward to incorporating new offerings like diagnostics and insurance to make Common Health the first port of call for people with diabetes, hypertension, and other chronic health needs.”
About Common Health
Common Health, Inc. is a purpose-driven company that helps families in Southeast Asia manage complex health needs like chronic diseases, pregnancy, and early childhood care. The company was founded in the United States in 2019 and started operations in Myanmar in 2021, helping healthcare providers deliver high-quality primary care and essential medications to families with children. With the launch of its new e-commerce platform, Common Health is now applying its capabilities to empower the 151 million people in Southeast Asia with diabetes and hypertension to save money and achieve better health. For more information, visit www.commonhealth.com.mm.
Contact Information:
Nang Nwe
Commercial Manager, Common Health
+95 9765 442 738
Original Source:
Common Health Launches Southeast Asia’s First E-Commerce Platform for Chronic Diseases
San Diego-Based Shoreline Recovery Center Addresses the Opioid Epidemic Among Young Adult Males With Education, Treatment and Comprehensive Programming
SAN DIEGO, March 18, 2023 (Newswire.com)
–
Shoreline Recovery Center is addressing the opioid crisis through a process that involves giving patients med…
Impact Report: Colossal Sets New Goal After Raising Over $9.6M in 2022
Favorite Chef, Skatepark Hero, and Super Mom to run this year
Colossal Management A global leader in modern giving.
…
The post Impact Report: Colossal Sets New Goal After Raising Over $9.6M in 2022 first appeared on RSVTV news.
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
dIFine 30 system is ZEUS Scientific’s complete solution for IFA slide processing and digital immunofluorescence imaging
dIFine 30 System
A complete system for IFA slide processing and digital immunofluorescence imaging – including cover slipping!
BRANCHBURG, N.J., March 17, 2023 (Newswire.com)
–
Today, ZEUS Scientific launched the dIFine 30 System, a powerful partnership pairing the ZEUS dIFine® digital immunofluorescence system with the new ZEUS SP30 slide processor. The SP30 is an easy-to-use and efficient walk-away benchtop instrument for IFA slide processing, designed to improve laboratory workflow and ensure high-quality results, including cover slipping. The SP30 can process up to 240 samples on 30 ZEUS IFA slides. With its three-probe system for fast, accurate pipetting and slide well washing, it precisely dispenses mounting media and adds coverslips, decreasing slide handling and the risk of artifacts/bubbles. The multi-drop individual well-to-well washing eliminates the risk of carryover or cross-contamination. ZEUS ANA IFA test kits feature ready-to-use reagents that can be directly loaded onto the SP30 – no pour off. Its user-friendly, intuitive software works with ZEUS dIFine, allowing for parallel processing and scanning sessions. The system connects to laboratories’ LIS to receive test requests and share the worklist with dIFine, boosting efficiency.
The FDA-cleared ZEUS dIFine System is the next generation in IFA imaging, interpretation, and pattern recognition, designed to acquire, analyze, display and store digital images of ZEUS IFA HEp-2 cells. An automated digital scanner with intelligent software, dIFine quickly delivers positive/negative results and is FDA-cleared to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal and mitochondrial)).* dIFine also instantly locates and identifies mitotic cells, assisting in pattern identification. The ability to quickly view/validate all negative samples saves users valuable time. The built-in pattern atlas can be used as a reference or training tool, allowing side-by-side comparison with ZEUS proprietary images aligned with ICAP nomenclature.
ANA HEp-2 IFA is the American College of Rheumatology (ACR) gold standard for ANA testing. A pioneer in IFA technology, ZEUS has continually delivered quality products and expertise in autoimmune serology that laboratories have relied upon since 1976.
For 45+ years, laboratories have trusted ZEUS Scientific to provide high-quality IFA ANA HEp-2 products. The ZEUS proprietary cell fixation process allows technologists to work with cells containing natural, unaltered antigens and provides clear, crisp images; excellent cell morphology; and a high number of mitotic cells, all which make pattern determination easier.
With this new launch, laboratories can take their ANA IFA testing to the next level by pairing ZEUS’s top-tier IFA ANA HEp-2 slides with the ZEUS dIFine 30 System. In addition, ZEUS is in the final phases of FDA submission for dIFine automated negative/positive determination and detection of anti-dsDNA (nDNA/Crithidia) antibodies in 2023.
For more information, please visit the ZEUS website or contact the ZEUS sales team.
* FDA 510(k) cleared. All suggested results obtained with ZEUS dIFine must be confirmed by a trained operator.
Contact Information:
Travis Smyre
Vice President Commercial
908-243-4911
Original Source:
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
dIFine 30 system is ZEUS Scientific’s complete solution for IFA slide processing and digital immunofluorescence imaging
dIFine 30 System
A complete system for IFA slide processing and digital immunofluorescence imaging – including cover slipping!
BRANCHBURG, N.J., March 17, 2023 (Newswire.com)
–
Today, ZEUS Scientific launched the dIFine 30 System, a powerful partnership pairing the ZEUS dIFine® digital immunofluorescence system with the new ZEUS SP30 slide processor. The SP30 is an easy-to-use and efficient walk-away benchtop instrument for IFA slide processing, designed to improve laboratory workflow and ensure high-quality results, including cover slipping. The SP30 can process up to 240 samples on 30 ZEUS IFA slides. With its three-probe system for fast, accurate pipetting and slide well washing, it precisely dispenses mounting media and adds coverslips, decreasing slide handling and the risk of artifacts/bubbles. The multi-drop individual well-to-well washing eliminates the risk of carryover or cross-contamination. ZEUS ANA IFA test kits feature ready-to-use reagents that can be directly loaded onto the SP30 – no pour off. Its user-friendly, intuitive software works with ZEUS dIFine, allowing for parallel processing and scanning sessions. The system connects to laboratories’ LIS to receive test requests and share the worklist with dIFine, boosting efficiency.
The FDA-cleared ZEUS dIFine System is the next generation in IFA imaging, interpretation, and pattern recognition, designed to acquire, analyze, display and store digital images of ZEUS IFA HEp-2 cells. An automated digital scanner with intelligent software, dIFine quickly delivers positive/negative results and is FDA-cleared to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal and mitochondrial)).* dIFine also instantly locates and identifies mitotic cells, assisting in pattern identification. The ability to quickly view/validate all negative samples saves users valuable time. The built-in pattern atlas can be used as a reference or training tool, allowing side-by-side comparison with ZEUS proprietary images aligned with ICAP nomenclature.
ANA HEp-2 IFA is the American College of Rheumatology (ACR) gold standard for ANA testing. A pioneer in IFA technology, ZEUS has continually delivered quality products and expertise in autoimmune serology that laboratories have relied upon since 1976.
For 45+ years, laboratories have trusted ZEUS Scientific to provide high-quality IFA ANA HEp-2 products. The ZEUS proprietary cell fixation process allows technologists to work with cells containing natural, unaltered antigens and provides clear, crisp images; excellent cell morphology; and a high number of mitotic cells, all which make pattern determination easier.
With this new launch, laboratories can take their ANA IFA testing to the next level by pairing ZEUS’s top-tier IFA ANA HEp-2 slides with the ZEUS dIFine 30 System. In addition, ZEUS is in the final phases of FDA submission for dIFine automated negative/positive determination and detection of anti-dsDNA (nDNA/Crithidia) antibodies in 2023.
For more information, please visit the ZEUS website or contact the ZEUS sales team.
* FDA 510(k) cleared. All suggested results obtained with ZEUS dIFine must be confirmed by a trained operator.
Contact Information:
Travis Smyre
Vice President Commercial
908-243-4911
Original Source:
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
4 Questions Spouses Should Ask Each Other Before Retirement
MILWAUKEE, March 16, 2023 (Newswire.com)
–
Northwestern Mutual: Retirement is a great stage of life for any couple, with the time to rest, relax, and spend th…
The post 4 Questions Spouses Should Ask Each Other Before Retirement first appeared on RSVTV news.
The Shocking Number of Gen Z’ers That Don’t Know Their Credit Score
NEW YORK, March 16, 2023 (Newswire.com)
–
Credello: A recent survey by credit.com found that 42% of Gen Z-ers don’t know their credit scores. Does this mean a major problem for them when it comes time to borrow money, or does it signify a shift in how future generations think about credit?
Why doesn’t Gen Z care about their credit scores?
Generation Z is the newest generation to enter the workforce and is taking a new perspective on how it views financial health. Previous generations saw their credit scores as a top priority for ensuring they could live comfortably.
But after watching the devastating economic fallout Millennials suffered, Gen Z has become more risk-averse to accruing debt. While their elders are searching for credit card refinancing and debt consolidation options, Gen Z’ers seem to be avoiding the idea of borrowing money altogether.
Consequently, the significance of a credit score doesn’t hold as much weight, even though a low score can still affect your chances of renting a home and even entering some career fields.
So which has to change, Gen Z’s outlook on debt or the world they’re entering?
Despite the interest, their credit scores are good
Interestingly, the data credit.com found in their surveys showed that their scores were surprisingly high despite Gen Z having less interest in their credit reports. 54% of those surveyed had credit scores between 799 – 850, averaging higher scores overall than Millennials and Gen X’ers.
How the financial world is changing
It seems that the financial world is taking this priority shift from the younger generation seriously and is beginning to enact new ways to make credit reporting more relevant with the times:
- The three main credit bureaus – Equifax, Experian, and TransUnion – have all agreed to remove some instances of medical debt from credit score calculations.
- “Buy Now, Pay Later” accounts, popular among younger consumers, will now be included in credit reports.
- “Trended data” will take a higher priority in scoring calculations, giving your report a more thorough analysis of your buying and spending than the simple “snapshot” currently used.
- Inclusion of rent, checking and savings account balances, and utility bill or streaming payments as optional data points. Currently, UltraFICO and Experian Boost are adding these as features to boost credit scores of those for whom mortgages and large personal loans are too far out of reach.
- New scoring models with updated algorithms. Both FICO and VantageScores, the main scoring algorithms used by lenders, have been recently upgraded to account for economic changes and how people spend money.
- New startup lending companies are leaning into the younger generation’s financial habits by removing the significance of credit scores in their decision-making metrics and relying more on historical spending habits and the average amount of cash on hand.
The bottom line
While there’s still a long way to go before Gen Z’s credit scores rival those of their elders, these changes show that the world is slowly starting to take them seriously and that it might be the corporations that need to adapt instead of the new consumers.
About Credello
Credello is a financial tech company offering personal finance tools that simplify financial decisions through personalized, on-demand recommendations — so users can borrow, save, or invest with confidence.
Credello believes that finding the right financial product should be as easy and interactive as online shopping, and we are on a mission to make that possible. For more information, please visit https://www.credello.com.
Contact Information:
Keyonda Goosby
Public Relations Specialist
(201) 633-2125
Original Source:
The Shocking Number of Gen Z’ers That Don’t Know Their Credit Score
The post The Shocking Number of Gen Z’ers That Don’t Know Their Credit Score first appeared on RSVTV news.
The Biggest Hidden Costs of Divorce in 2023
NEW YORK, March 16, 2023 (Newswire.com)
–
Credello: Nobody gets into a marriage thinking they’ll divorce one day. If they do, it probably means they reached a…
The post The Biggest Hidden Costs of Divorce in 2023 first appeared on RSVTV news.
Millennials Are Using Credit Cards for Their Emergency Funds, Which is Not Great
NEW YORK, March 16, 2023 (Newswire.com)
–
Credello: Millennials are the generation of individuals born between 1981 and 1996. They’re adults now, and they’re …
The post Millennials Are Using Credit Cards for Their Emergency Funds, Which is Not Great first appeared on RSVTV news.